Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, Multi-Center Phase 3 Clinical Trial to Determine Safety, Efficacy, and Immunogenicity of Booster Vaccination Against SARS-CoV-2

NCT05077176 is registered in ClinicalTrials.gov with Health Institutes of Turkey as lead sponsor.

NCT NCT05077176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05077176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, Multi-Center Phase 3 Clinical Trial to Determine Safety, Efficacy, and Immunogenicity of Booster Vaccination Against SARS-CoV-2
Lead sponsor
Health Institutes of Turkey
Phase
Phase 3
Overall status
Completed
Start date
October 8, 2021
Completion date
February 5, 2024
Enrollment
4,340 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov-2 infection